Technologic (r)evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region

Sentinel lymph node (SN) biopsy (SNB) has proven to be a valuable tool for staging melanoma patients. Since its introduction in the early 1990s, this procedure has undergone several technologic refinements, including the introduction of SPECT/CT, as well as radioguidance and fluorescence guidance. The purpose of the current study was to evaluate the effect of this technologic evolution on SNB in the head and neck region. The primary endpoint was the false-negative (FN) rate. Secondary endpoints were number of harvested SNs, overall operation time, operation time per harvested SN, and postoperative complications. Methods: A retrospective database was queried for cutaneous head and neck melanoma patients who underwent SNB at The Netherlands Cancer Institute between 1993 and 2016. The implementation of new detection techniques was divided into 4 groups: 1993-2005, with preoperative lymphoscintigraphy and intraoperative use of both a y-ray detection probe and patent blue (n = 30); 2006-2007, with addition of preoperative road maps based on SPECT/CT (n = 15); 2008-2009, with intraoperative use of a portable y-camera (n = 40); and 2010-2016, with addition of near-infrared fluorescence guidance (n = 192). Results: In total, 277 patients were included. At least 1 SN was identified in all patients. A tumor-positive SN was found in 59 patients (21.3%): 10 in group 1 (33.3%), 3 in group 2 (20.0%), 6 in group 3 (15.0%), and 40 in group 4 (20.8%). Regional recurrences in patients with tumor negative SNs resulted in an overall FN rate of 11.9% (group 1, 16.7%; group 2, 0%; group 3, 14.3%; group 4, 11.1%). The number of harvested nodes increased with advancing technologies (P = 0.003), whereas Breslow thickness and operation time per harvested SN decreased (P = 0.003 and P = 0.017, respectively). There was no significant difference in percentage of tumor-positive SNs, overall operation time, and complication rate between the different groups. Conclusion: The use of advanced detection technologies led to a higher number of identified SNs without an increase in overall operation time, possibly indicating an improved surgical efficiency. Operation time per harvested SN decreased; the average FN rate remained 11.9% and was unchanged over 23 y. There was no significant change in postoperative complication rate.Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas

Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy EDITORIAL COMMENT

Prostatic carcinom

Innovating image-guided surgery: Introducing multimodal approaches for sentinel node detection

Founded on Halsted’s hypothesis of sequential tumor spread, selective biopsy of the tumor draining lymph nodes enables early detection of clinically occult nodal metastases while sparing patients the morbidity of an unnecessary lymph node dissection. Originally introduced for melanoma and breast cancer, the sentinel node (SN) biopsy is a multidisciplinary diagnostic procedure based on the injection of a radiocolloid followed by lymphatic mapping using lymphoscintigraphy and SPECT/CT to identify the SNs. Intraoperatively, SNs are traditionally localized using a gamma ray detection probe and a separate injection of blue dye to visualize the SNs. Over the last decade, the procedure has expanded to malignancies with lymphatic drainage to areas of more complex anatomy or located deeply in the abdomen. SN biopsy in these patients may be challenging and may benefit from additional intraoperative tools. This thesis focuses on the clinical introduction of novel multimodal approaches in order to help optimize the SN procedure

The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies.

The increasing availability of new imaging technologies and tracers has enhanced the application of nuclear molecular imaging in urogenital interventions. In this context, preoperative nuclear imaging and radioactivity-based intraoperative surgical guidance have become important tools for the identification and anatomical allocation of tumor lesions and/or suspected lymph nodes. Fluorescence guidance can provide visual identification of the preoperatively defined lesions during surgery. However, the added value of fluorescence guidance is still mostly unknown. This review provides an overview of the role of fluorescence imaging in radioguided surgery in urogenital malignancies. The sentinel node (SN) biopsy procedure using hybrid tracers (radioactive and fluorescent component) serves as a prominent example for in-depth evaluation of the complementary value of radio- and fluorescence guidance. The first large patient cohort and long-term follow-up studies show: 1) improvement in the SN identification rate compared to blue dye; 2) improved detection of cancer-positive SNs; and 3) hints towards a positive effect on (biochemical) recurrence rates compared to extended lymph node dissection. The hybrid tracer approach also highlights the necessity of a preoperative roadmap in preventing incomplete resection. Recent developments focus on receptor-targeted approaches that allow intraoperative identification of tumor tissue. Here radioguidance is still leading, but fluorescent and hybrid tracers are also finding their way into the clinic. Emerging multiwavelength approaches that allow concomitant visualization of different anatomical features within the surgical field may provide the next step towards even more refined procedures

Feasibility of 3D Intraoperative Freehand SPECT Probe Imaging for Radioguided Tumour Excision and Sentinel Node Biopsy in Breast Cancer

Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas

Relationship Between Intraprostatic Tracer Deposits and Sentinel Lymph Node Mapping in Prostate Cancer Patients

Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas

165. Feasibility of 3D intraoperative freehand SPECT probe imaging for radioguided tumor excision and sentinel node biopsy in breast cancer

Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas